跳至主要内容
临床试验/NCT00959153
NCT00959153Unknown3 期

Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney (Renal Pelvis)

Advance Shockwave Technology GmbH3 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2010年6月1日最近更新:
适应症

试验速览

阶段
3 期
发起方
入组人数
20
试验地点
3
主要终点
stone fragmentation

研究概览

简要总结

A total of 20 subjects presenting with urinary stone(s) in the kidney or ureter will be treated with an extracorporeal shockwave lithotripsy device to fragment the stones. Subjects will be followed for 14 days. If at the 14 day follow-up visit the subject continues to present with a stone size 4 mm or greater will have an option of retreatment or other intervention. If the subject consents to be retreated at this time, this subject will be followed up for another 14 days.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of a solitary Urinary stones in the renal pelvis or renal calyces or ureter
  • Presence of one stone greater than 4 mm and less than 12 mm

排除标准

  • Urinary tract obstruction, acute or unresolved cholecystitis, cholangitis, pancreatitis or obstruction of the biliary duct system
  • Impaction of stone to be treated
  • Staghorn stones
  • Failed or inadequate lithotripsy procedure within 3 months prior to study
  • Coagulation abnormalities or anticoagulation therapy
  • Pregnant or females of child-bearing potential General, spinal or epidural anesthesia is contraindicated
  • Can not be positioned correctly for fluoroscopic imaging

结局指标

主要结局

stone fragmentation

时间窗: 14 days

次要结局

未报告次要终点

研究者

发起方
Advance Shockwave Technology GmbH
申办方类型
Industry

研究点 (3)

Loading locations...

相似试验